No Picture
Trading Ideas

Oil Extends Drop After Report Stokes Concerns Over Excess Supply

(Bloomberg) — Oil fell a second day after a report showing a jump in U.S. crude stockpiles raised fresh concerns over excess supply, while doubts are also creeping in over Russia’s commitment to maintaining production curbs.Futures in New York fell as much as 2.6%, adding to Wednesday’s 4.5% drop. The American Petroleum Institute reported that oil inventories rose by 8.73 million barrels last week, according to people familiar. If confirmed by government data on Thursday it would reverse two weeks of declines — an indication that record supply cuts are not draining a massive glut fast enough. Gasoline supplies also …read more […]

No Picture
Trading Ideas

Is Hydrogen Fuel Cell Technology the Future of EVs?

Countries around the world are focused on mitigating the effects of climate change. And getting rid of greenhouse gases is fast becoming a top focus.
One of the quickest ways to lower pollution is to reduce fossil fuel burning. The nation’s transportation infrastructure is a great place to start, as it’s responsible for 29% of greenhouse gases.
But we can’t just stop burning oil and natural gas in a year or two…
We can, however, start burning less of them right now thanks to hydrogen gas.
When hydrogen is burned, it combines with oxygen. This reaction generates energy and heat. But that’s where the …read more […]

No Picture
Trading Ideas

You Like This $12 Stock From Brazil?

You’ve surely seen the news…
Brazil is quickly emerging as the next global COVID-19 hot spot.
The country now has the second-highest number of coronavirus cases in the world after the U.S. and far worse healthcare infrastructure.
But through it all, Brazilian President Jair Bolsonaro continues to dismiss the threat of the virus, saying that quarantines and lockdowns could have a worse impact on Brazil’s economy.
It’s shaping up to be a very dangerous situation in the coming days and weeks…
So that’s why I was quite interested when one of my researchers, we’ll call him B.D., approached me and suggested that I look into …read more […]

No Picture
Trading Ideas

Gilead’s Remdesivir May Be a Coronavirus Silver Bullet — But It’s Already Baked in the Stock Price

RBC Capital analyst Brian Abrahams is a fan of Gilead Sciences (GILD) — in particular, its Biktarvy 3-in-1 drug cocktail for treating HIV-1.It is “Biktarvy’s strong profile and robust launch, along with favorable demographic and pricing dynamics,” that Abrahams says “will underpin good HIV franchise sustainability through at least 2025” for Gilead Sciences. Combined with the company’s better known continued hepatitis-C drug franchise, which is experiencing declining revenue but market share and pricing stability, and should therefore be able to generate “~$17B in cash flows over the next decade,” says the analyst, Gilead Sciences is likely to outperform the market.At …read more […]

No Picture
Trading Ideas

HP Inc. misses on Q2 revenue estimates despite work-from-home demand

On Wednesday, computing giant HP reported mixed second-quarter results. Total revenue came in at $12.5 billion, compared to $12.86 billion expected, and earnings per share topped estimates ($0.51 vs. $045 expected). Meanwhile, sales at HP’s personal systems and and printing segments dropped 7% and 19%, respectively, from the prior year. Yahoo Finance’s Myles Udland breaks down the company’s report. …read more […]